Positions 26–50 of 62.
Result first, context after: 12th independent test on SGN — 98.1% on a claimed 98.0%, and the trend is the interesting part . Everything below is how it was ordered,…
regulatory is the most under-discussed thing on this board. Change my mind, genuinely — I have no stake in being right about this. The three questions, kept separate,…
Something I keep coming back to: the pentadecapeptide question that gets asked weekly, answered properly. Bought small, tested identity first, and only then thought…
three years of sequence threads, summarised so you do not have to read them. It is the sort of thing everyone half-believes and nobody writes down. Every claim I could…
Vendor-level purity averages over time, built from independent results rather than vendor claims. Transparent methodology, open dataset.
Browse resultswhy does nobody talk about sequence. If this has been answered properly somewhere, link me and I will delete. Assumed regulatory status was static and it was not.…
The claim in the title is exactly the claim I am making: 18th independent test on SWB — 99.1% on a claimed 99.0%, and the trend is the interesting part. Nothing implied…
Check-in as promised in the title: week 39 check-in — 12kg down, injection-site soreness manageable, one thing confusing me. week 39 and 12kg. Those are measured, not…
pentadecapeptide is not what most of this community thinks it is. Two minutes of reading now saves an argument later. The published literature is overwhelmingly…
help me understand rodent data, I have read the wiki twice. If this has been answered properly somewhere, link me and I will delete. Assumed regulatory status was…
3 months in and regulatory is still the thing I get wrong. Full detail below, and I have tried to keep the editorialising out of it. Numbers, in the order they matter:…
Here it is: anyone else notice pentadecapeptide kicking in around week 54. One person, one log, no control group, so read it accordingly. Why identity, not purity, is…
Slightly embarrassed to be asking this, but: can we stop arguing about regulatory until somebody posts a number. Bought small, tested identity first, and only then…
Homopeptide BPC — Medutest came back 98.6% against a claimed 98.0%. One vial, one service, one member paying, which is the only kind of result this board should treat…
The title is the whole question — why does nobody talk about tendon — but here is why I am asking. Kept a reconstituted vial too long out of curiosity and learned…
Putting this to the board: proposal — a flair for rodent data posts. The evidence base, described honestly, which almost no summary of it does. The published literature…
Reference standards, analytical reagents and system-suitability material. If you are running your own method, start with a known.
Reference standardshow do you actually verify sequence. Searched first, found three threads that contradict each other, hence the post. Every claim I could trace in this board went back…
tendon: what the trials say vs what this community says — a position I have arrived at slowly and would like tested. The evidence base, described honestly, which almost…
Thinking out loud about this: BPC-157 is the most under-discussed thing on this board. The three questions, kept separate, because this board runs them together…
The title is the argument: three years of regulatory threads, summarised so you do not have to read them. Here is the rest of it. Ask for the theoretical mass alongside…
sequence — 10 things I got wrong before I got it right. Not a hot take, just something I have not seen said plainly here. Every claim I could trace in this board went…
is it normal to get nausea at week 78. Same spreadsheet I have been keeping since the start, nothing retrofitted. Regulatory classification differs between…
the pentadecapeptide rule is doing its job and people should stop complaining — with the counter-argument included, because I find it fairly persuasive. Paid for…
The title is the argument: rodent data — 9 things I got wrong before I got it right. Here is the rest of it. Ask for the theoretical mass alongside the measured one. It…
Reporting in. small win: pentadecapeptide stopped being a problem at week 74. Assumed regulatory status was static and it was not. Checked again this year and the…
genuine question about sequence that I am slightly embarrassed to ask. I would rather ask a basic question now than get this wrong quietly for two months. Purity by…
BPC-157 as it actually is: a pentadecapeptide with a genuinely interesting rodent tendon-and-gut literature, near-zero controlled human data, a naming and sequence mess in the supply chain, and a regulatory status that changed sharply in several countries.
Certified reference materials for peptide identity and purity work.
sigmaaldrich.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference